Associazione Nazionale Medici Cardiologi Ospedalieri

www.anmco.it

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
RBM20 VARIANTS RELATED CARDIOMYOPATHY: AN ITALIAN CASE SERIES
Anno:
2023
Background: RNA-binding motif protein 20 (RBM20) regulates post-transcriptional splicing, particularly in sarcomeric, but also in other cardiac genes crucial for homeostasis. RBM20 variants are a rare cause of cardiomyopathy (CMP), but genotype-phenotype correlation is still elusive, starting from the type of CMP (dilated, non-compacted, hypertrophic, and even restrictive phenotypes…
Leggi di più
ANAEMIA AND CONGESTION IN HEART FAILURE: CORRELATIONS AND PROGNOSTIC ROLE
Anno:
2023
Background. The relationship between anaemia and congestion in HF and its prognostic role are controversial. The aim of this study was to evaluate the relationship between anaemia and biomarkers of central/peripheral congestion in HF and the impact on mortality. Methods. We retrospectively evaluated 434 acute/chronic HF (AHF/CHF) patients. Anaemia…
Leggi di più
24-HOUR PULMONARY ARTERY ELASTANCE IS THE STRONGEST HEMODYNAMIC PREDICTOR OF IN-HOSPITAL MORTALITY IN ACUTE DECOMPENSATED HEART FAILURE-RELATED CARDIOGENIC SHOCK
Anno:
2023
Aim     The initial bundle of cares strongly affects hemodynamics in acute decompensated heart failure cardiogenic shock (ADHF-CS). We sought to characterize whether 24-hour hemodynamic profiling provides superior prognostic information as compared to admission assessment, and which hemodynamic parameters best predict in-hospital death.   Methods and results We included 99…
Leggi di più
Left ventricular outflow tract velocity-time integral (LVOT-VTI) improves risk stratification in heart failure patients with secondary mitral regurgitation
Anno:
2023
Background: Reduced left ventricular ejection fraction (LVEF) has been used as a key criterion for the management of mitral regurgitation (MR) in patients with heart failure (HF), including the decision about mitral valve repair. However, LVEF, not taking into account mitral regurgitant volume, may be an imprecise predictor of…
Leggi di più
SIDE EFFECTS OF SGLT-2 INHIBITORS IN PATIENTS WITH HEART FAILURE: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Anno:
2023
Background: sodium-glucose cotransoporter-2 inhibitors (SGLT-2Is) improve prognosis in heart failure patients both with reduced (HFrEF) and preserved ejection fraction (HFpEF). However, these drugs can have some side effects. Purpose: estimate the relative risk of side effects in HF patients treated with SGLT-2Is irrespectively from left ventricular EF and setting…
Leggi di più
TEMPORAL TREND MORTALITY AND IN-HOSPITAL MORTALITY PREDICTORS IN AN ISCHEMIC CARDIOGENIC SHOCK POPULATION: A 10 YEARS SINGLE-CENTRE RETROSPECTIVE STUDY
Anno:
2023
Background Cardiogenic shock (CS) after acute myocardial infarction (AMI) represents the most severe form of acute heart failure (AHF) syndromes with an high rate of in-hospital mortality. Purpose describe predictors of in-hospital mortality; evaluate ten years mortality temporal trend in our CICU; assess the feasibility of CARDSHOCK risk score;…
Leggi di più

A.N.M.C.O. – Via La Marmora 36, 50121 Firenze (Italy) – Partita I.V.A. 05469530488 – Codice Fiscale 01301130488 – Privacy
www.anmco.it | segreteria@anmco.it

Seguici su

Facebook Twitter Youtube Linkedin Instagram Telegram